1-197101567-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018136.5(ASPM):​c.7684A>G​(p.Ser2562Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 1,606,932 control chromosomes in the GnomAD database, including 129,342 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 8729 hom., cov: 32)
Exomes 𝑓: 0.40 ( 120613 hom. )

Consequence

ASPM
NM_018136.5 missense

Scores

1
7
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 1.82

Publications

37 publications found
Variant links:
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
ASPM Gene-Disease associations (from GenCC):
  • microcephaly 5, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005072117).
BP6
Variant 1-197101567-T-C is Benign according to our data. Variant chr1-197101567-T-C is described in ClinVar as Benign. ClinVar VariationId is 21605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018136.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPM
NM_018136.5
MANE Select
c.7684A>Gp.Ser2562Gly
missense
Exon 18 of 28NP_060606.3
ASPM
NM_001206846.2
c.4066-5403A>G
intron
N/ANP_001193775.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPM
ENST00000367409.9
TSL:1 MANE Select
c.7684A>Gp.Ser2562Gly
missense
Exon 18 of 28ENSP00000356379.4
ASPM
ENST00000294732.11
TSL:1
c.4066-5403A>G
intron
N/AENSP00000294732.7
ASPM
ENST00000367408.6
TSL:1
n.2108-5403A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.304
AC:
46063
AN:
151450
Hom.:
8733
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0942
Gnomad AMI
AF:
0.405
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.156
Gnomad SAS
AF:
0.290
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.330
GnomAD2 exomes
AF:
0.335
AC:
83182
AN:
248174
AF XY:
0.346
show subpopulations
Gnomad AFR exome
AF:
0.0888
Gnomad AMR exome
AF:
0.210
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.165
Gnomad FIN exome
AF:
0.367
Gnomad NFE exome
AF:
0.432
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
AF:
0.397
AC:
578458
AN:
1455362
Hom.:
120613
Cov.:
52
AF XY:
0.397
AC XY:
287166
AN XY:
724186
show subpopulations
African (AFR)
AF:
0.0824
AC:
2753
AN:
33408
American (AMR)
AF:
0.217
AC:
9652
AN:
44516
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
10246
AN:
26078
East Asian (EAS)
AF:
0.154
AC:
6096
AN:
39648
South Asian (SAS)
AF:
0.308
AC:
26510
AN:
86154
European-Finnish (FIN)
AF:
0.372
AC:
18786
AN:
50550
Middle Eastern (MID)
AF:
0.371
AC:
2133
AN:
5754
European-Non Finnish (NFE)
AF:
0.433
AC:
479913
AN:
1109080
Other (OTH)
AF:
0.372
AC:
22369
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
18598
37196
55794
74392
92990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14118
28236
42354
56472
70590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.304
AC:
46063
AN:
151570
Hom.:
8729
Cov.:
32
AF XY:
0.299
AC XY:
22162
AN XY:
74026
show subpopulations
African (AFR)
AF:
0.0940
AC:
3896
AN:
41464
American (AMR)
AF:
0.267
AC:
4058
AN:
15178
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
1380
AN:
3462
East Asian (EAS)
AF:
0.157
AC:
807
AN:
5132
South Asian (SAS)
AF:
0.292
AC:
1408
AN:
4820
European-Finnish (FIN)
AF:
0.369
AC:
3891
AN:
10534
Middle Eastern (MID)
AF:
0.445
AC:
130
AN:
292
European-Non Finnish (NFE)
AF:
0.435
AC:
29437
AN:
67684
Other (OTH)
AF:
0.328
AC:
689
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1455
2911
4366
5822
7277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
40481
Bravo
AF:
0.286
TwinsUK
AF:
0.433
AC:
1604
ALSPAC
AF:
0.428
AC:
1651
ESP6500AA
AF:
0.104
AC:
456
ESP6500EA
AF:
0.433
AC:
3718
ExAC
AF:
0.340
AC:
41233
Asia WGS
AF:
0.201
AC:
702
AN:
3476
EpiCase
AF:
0.422
EpiControl
AF:
0.425

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Microcephaly 5, primary, autosomal recessive Benign:3Other:1
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.28
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
T
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Pathogenic
3.2
M
PhyloP100
1.8
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.36
Sift
Uncertain
0.021
D
Sift4G
Uncertain
0.019
D
Polyphen
1.0
D
Vest4
0.52
ClinPred
0.065
T
GERP RS
5.2
Varity_R
0.14
gMVP
0.060
Mutation Taster
=75/25
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41310927; hg19: chr1-197070697; COSMIC: COSV54126776; API